04/01/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
4:53 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Jerman Michael Allen (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/22/2024
6:00 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
12/27/2023
4:27 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/27/2023
4:33 PM | Bay Shore Trust (Reporting)
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:50 PM | MIRA Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/01/2023
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
3:15 PM | Jerman Michael Allen (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
3:18 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/20/2023
7:10 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:31 PM | Daly Brian Frederick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2023
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
3:23 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/12/2023
3:26 PM | McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2023
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 424B3 | |
09/15/2023
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/31/2023
4:27 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
4:38 PM | Bay Shore Trust (Reporting)
Cappy George (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | Chapman Christopher C JR (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | MIRA Pharmaceuticals (Issuer)
Nicholoudis Christos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:25 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D | |
08/04/2023
12:42 PM | Bay Shore Trust (Reporting)
Cappy George (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
11:59 AM | MIRA Pharmaceuticals (Filer)
| Form 424B1 | |
08/04/2023
12:01 PM | MIRA Pharmaceuticals (Filer)
| Form 424B4 | |
08/02/2023
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
08/02/2023
4:58 PM | Kroenig Bradley (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:00 PM | McColl Hugh III (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:03 PM | MIRA Pharmaceuticals (Issuer)
Nicholoudis Christos (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:05 PM | MIRA Pharmaceuticals (Issuer)
Tuck Talhia (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:08 PM | MIRA Pharmaceuticals (Issuer)
Vorhoff David C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Elon Musk’s Next Move Will Disrupt AI Forever (Ad) A revolutionary venture that is set to get rolled out by May 16.
One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100. Get all the information here. |
08/02/2023
5:10 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:13 PM | Bay Shore Trust (Reporting)
Cappy George (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
4:49 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
4:52 PM | Chapman Christopher C JR (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
4:55 PM | Kaplin Adam (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2023
4:24 PM | MIRA Pharmaceuticals (Filer)
| Form CERT | |
07/31/2023
2:54 PM | MIRA Pharmaceuticals (Filer)
| Form 8-A12B | |
07/28/2023
2:14 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/21/2023
4:20 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/18/2023
4:14 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/14/2023
4:08 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
06/29/2023
3:39 PM | MIRA Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
